Distigmine Bromide
| Code | Size | Price |
|---|
| TAR-T7825-5mg | 5mg | £537.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T7825-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T7825-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Distigmine Bromide is an acetylcholinesterase inhibitor. It is used for the treatment of underactive neurogenic bladder and myasthenia gravis.
CAS:
15876-67-2
Formula:
C22H32Br2N4O3
Molecular Weight:
560.331
Purity:
0.98
SMILES:
[Br-].[Br-].CN(CCCCCCN(C)C(=O)c1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1
References
Mohamed GG, Rizk MS, Zaky Frag EY. Spectrophotometric Determination of Distigmine Bromide, Cyclopentolate HCl, Diaveridine HCl and Tetrahydrozoline HCl via Charge Transfer Complex Formation with TCNQ and TCNE Reagents. Iran J Pharm Res. 2015 Summer;14(3):701-14. PubMed PMID: 26330858; PubMed Central PMCID: PMC4518098.
Izumi K, Maolake A, Maeda Y, Shigehara K, Namiki M. Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder. Minerva Urol Nefrol. 2014 Dec;66(4):241-7. PubMed PMID: 25531193.
Kobayashi K, Sekiguchi H, Sato N, Hirose Y. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment]. Chudoku Kenkyu. 2016 Mar;29(1):26-9. Japanese. PubMed PMID: 27255021.
Sugaya K, Kadekawa K, Onaga T, Ashitomi K, Mukouyama H, Nakasone K, Shimabukuro H, Shimabukuro S, Matayoshi Y, Hokama S, Touyama Y, Nishijima S. [Effect of distigmine at 5 mg daily in patients with detrusor underactivity]. Nihon Hinyokika Gakkai Zasshi. 2014 Jan;105(1):10-6. Japanese. PubMed PMID: 24605581.